Bioactive lipid profiles as non-invasive biomarkers of advanced fibrosis in people with HIV/HCV co-infection
Document Type
Journal Article
Publication Date
7-1-2025
Journal
Metabolomics : Official journal of the Metabolomic Society
Volume
21
Issue
4
DOI
10.1007/s11306-025-02293-5
Keywords
Coinfecton; Eicosanoid; Fibrosis; HIV; Hepatitis C virus; Metabolite; Metabolomics; Oxylipin
Abstract
Non-invasive assessments for advanced liver fibrosis have limited accuracy in persons with human immunodeficiency virus (HIV) (PWH) who have hepatitis C virus (HCV) co-infection, and new tools are needed. Our aim was to discover oxylipin profiles associated with advanced liver fibrosis in treatment-naïve patients with HIV/HCV co-infection. Serum samples from 40 PWH with HCV were subjected to targeted oxylipin analysis. A model with AST and seven metabolites, including 5(S)-HEPE, 8-HETE, 14,15-DiHETrE, 4-HDoHE, 14- HDoHE, 7-HDoHE, and 9,10-DiHOME yielded an area under the receiver operating characteristic curve of 0.93, with optimal sensitivity and specificity of 86% and 88%, respectively.
APA Citation
Lee, Tzu-Hao; Wegermann, Kara; Safeek, Rachel; Mock, Meredith; Lusk, Sam; John-Williams, Lisa St; Thompson, Will J.; Lucas, Joseph E.; Moseley, M Arthur; Patel, Keyur; and Naggie, Susanna, "Bioactive lipid profiles as non-invasive biomarkers of advanced fibrosis in people with HIV/HCV co-infection" (2025). GW Authored Works. Paper 7676.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/7676
Department
Physician Assistant Studies